These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17229880)

  • 1. Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses.
    Lee HG; Zhu X; Castellani RJ; Nunomura A; Perry G; Smith MA
    J Pharmacol Exp Ther; 2007 Jun; 321(3):823-9. PubMed ID: 17229880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease.
    Lee HG; Casadesus G; Zhu X; Takeda A; Perry G; Smith MA
    Ann N Y Acad Sci; 2004 Jun; 1019():1-4. PubMed ID: 15246983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
    Levi O; Dolev I; Belinson H; Michaelson DM
    J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease.
    Wang X; Su B; Perry G; Smith MA; Zhu X
    Free Radic Biol Med; 2007 Dec; 43(12):1569-73. PubMed ID: 18037122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's beta-amyloid peptide as a source of neurotoxic free radicals: the role of structural effects.
    Pogocki D
    Acta Neurobiol Exp (Wars); 2003; 63(2):131-45. PubMed ID: 12926540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model.
    Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
    Mol Pharm; 2010 Jun; 7(3):815-25. PubMed ID: 20230014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cell cycle in Alzheimer disease: a unique target for neuropharmacology.
    Webber KM; Raina AK; Marlatt MW; Zhu X; Prat MI; Morelli L; Casadesus G; Perry G; Smith MA
    Mech Ageing Dev; 2005 Oct; 126(10):1019-25. PubMed ID: 15936057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-amyloid expression, release and extracellular deposition in aged rat brain slices.
    Marksteiner J; Humpel C
    Mol Psychiatry; 2008 Oct; 13(10):939-52. PubMed ID: 17712316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathology of Alzheimer disease: pathognomonic but not pathogenic.
    Castellani RJ; Lee HG; Zhu X; Nunomura A; Perry G; Smith MA
    Acta Neuropathol; 2006 Jun; 111(6):503-9. PubMed ID: 16718346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress.
    Lee KW; Kim JB; Seo JS; Kim TK; Im JY; Baek IS; Kim KS; Lee JK; Han PL
    J Neurochem; 2009 Jan; 108(1):165-75. PubMed ID: 19012747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress increases levels of endogenous amyloid-beta peptides secreted from primary chick brain neurons.
    Goldsbury C; Whiteman IT; Jeong EV; Lim YA
    Aging Cell; 2008 Oct; 7(5):771-5. PubMed ID: 18691184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of intracellular amyloid beta in Alzheimer's disease.
    Li M; Chen L; Lee DH; Yu LC; Zhang Y
    Prog Neurobiol; 2007 Oct; 83(3):131-9. PubMed ID: 17889422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons.
    Shelat PB; Chalimoniuk M; Wang JH; Strosznajder JB; Lee JC; Sun AY; Simonyi A; Sun GY
    J Neurochem; 2008 Jul; 106(1):45-55. PubMed ID: 18346200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress promotes JNK-dependent amyloidogenic processing of normally expressed human APP by differential modification of alpha-, beta- and gamma-secretase expression.
    Quiroz-Baez R; Rojas E; Arias C
    Neurochem Int; 2009 Dec; 55(7):662-70. PubMed ID: 19560504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.
    Melo JB; Sousa C; Garção P; Oliveira CR; Agostinho P
    Eur J Neurosci; 2009 Feb; 29(3):455-64. PubMed ID: 19222556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases.
    Ferreira ST; Vieira MN; De Felice FG
    IUBMB Life; 2007; 59(4-5):332-45. PubMed ID: 17505973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
    Sola Vigo F; Kedikian G; Heredia L; Heredia F; Añel AD; Rosa AL; Lorenzo A
    Neurobiol Aging; 2009 Sep; 30(9):1379-92. PubMed ID: 18187234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches.
    Van Broeck B; Van Broeckhoven C; Kumar-Singh S
    Neurodegener Dis; 2007; 4(5):349-65. PubMed ID: 17622778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond amyloid: the next generation of Alzheimer's disease therapeutics.
    Seabrook GR; Ray WJ; Shearman M; Hutton M
    Mol Interv; 2007 Oct; 7(5):261-70. PubMed ID: 17932415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid beta protein and Alzheimer disease.
    Square D
    CMAJ; 1997 Apr; 156(7):1040-2. PubMed ID: 9099177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.